Our team is not only important for Galecto – their knowledge, expertise and well-being are fundamentally connected to the success of our business as their enthusiasm and commitment are essential in driving our research programs forward.
Being a research powerhouse, we believe that an inclusive environment with diverse teams creates higher engagement, better solutions, and higher productivity, and is crucial to our efforts to bring better treatments to patients and improve their quality of life. We pride ourselves on representing a team of more than 15 nationalities, multiple scientific disciplines, and degrees, equally divided between genders.
We currently have no open positions.
Please check back as we will most certainly be looking for great people to join our team in the future.
Note on Fraudulent Job Offers
Galecto has received reports of people receiving fraudulent offers of employment from us. The fraudulent offer process includes individuals posing as Galecto executives by email, text and through LinkedIn and extending verbal and written fraudulent offers of employment. The persons making these fraudulent offers often request sensitivepersonal information as part of the “hiring process”, including copies of drivers’ licenses, passports and/or IRS Form W-4 information.
How do I know if I received a fraudulent offer?
Fake interview requests, often sent by email, text or through LinkedIn, and offer letters, may include our logo orexecutive signature making them appear authentic. These emails and/or offer letters often look trustworthy at first blush, so vigilance is necessary. The only legitimate business email domain we use is @galecto.com and our employees will never use a gmail or other personal email address to contact you. In addition, we will not contact you via text message or conduct an interview through a chat.
If you applied for a Galecto position on any website other than ours you may have been a target of the scammersand not involved in an actual Galecto hiring process. You should promptly contact Galecto’s Head of People, Pernille Aasholm, at email@example.com to verify the legitimacy of the job opportunity.
What should I do if believe I am the victim of a fraudulent employment scheme?
Legitimate Galecto employees will never ask you to provide personal information or ID via email, text or telephone aspart of our hiring process, and so under no circumstances should you provide any personal information to any recruiters, or make any purchases at their request. You should cease all further communication with these individuals, and under no circumstances should you click any links that they may have sent you.
If you received what you believe is a fake offer letter and provided any personal information or made purchases as part of a fraudulent offer process, we recommend you immediately:
- contact law enforcement to notify them that you may have been the victim of identity theft;
- contact your bank or credit card provider and let them know your account may have been compromised;
- contact your email provider — such as Gmail, Yahoo, or AOL — to alert them about the email address that was used in the fraudulent scheme; and/or
- forward the message to firstname.lastname@example.org.
To assist law enforcement in investigating these matters, please retain a copy of all correspondence relating to the fraudulent offer.
If you have been a victim of this scam, we sincerely regret the discomfort, inconvenience, and grief this incident may have caused you, as well as the time it has wasted in your job search. We sincerely appreciate your interest in Galecto, and we encourage you to view our legitimate job postings on this page.
Galecto is not responsible for fraudulent offers or requests for personal information, and advises candidates to follow the guidance provided above.
Galecto, Inc is a biotech company with offices in Copenhagen, Boston, London, Montreal, Gothenburg, and Edinburgh. Galecto, Inc develops small molecule based therapeutics for the treatment of severe diseases, focusing on fibrosis and cancer. Our most advanced program is in clinical Phase IIB for the treatment of Idiopathic Pulmonary Fibrosis.
We encourage anyone interested in a job to apply, irrespective of gender, age, race, religion, or ethnicity.